VESTA THERAPEUTICS INC has a total of 42 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and Taiwan. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are FULLHOPE BIOMEDICAL CO LTD, PROMETHERA BIOSCIENCES S A /N V and BIORESTORATIVE THERAPIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Taiwan | 5 | |
#4 | Canada | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | China | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Australia | 2 | |
#9 | Brazil | 2 | |
#10 | Israel | 2 | |
#11 | Mexico | 2 | |
#12 | Argentina | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Ruiz Joseph Charles | 20 |
#2 | Hoynowski Steven Michael | 10 |
#3 | Ludlow John W | 10 |
#4 | Sherwood Sonya | 7 |
#5 | Johnston Mark | 6 |
#6 | Reid Lola M | 5 |
#7 | Clark Jennifer C | 5 |
#8 | Bruce Andrew T | 5 |
#9 | Furth Mark E | 5 |
#10 | Susick Robert L Jr | 5 |
Publication | Filing date | Title |
---|---|---|
MX2010012730A | Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells. | |
US2010087000A1 | Hepatic progenitor cell and method of isolating same | |
EP2183356A1 | Methods of reducing intracellular fats from mammalian cells | |
EP2044195A2 | Matrix and method for isolation of hepatic progenitor cells | |
US2007148141A1 | Method of using hepatic progenitors in treating liver dysfunction | |
EP1576117A2 | Method of obtaining viable human liver cells, including hepatic stem/progenitor cells | |
KR20050050075A | Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |